Patents by Inventor Liren Tang

Liren Tang has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Substituted hydroxystilbenes as AhR and Nrf2 modulators and their therapeutic applications
    Patent number: 11000485
    Abstract: It discloses a compound of formula I that inhibits the activities of numerous of protein kinases involving the signaling of inflammatory cytokines, therefore, the compound can be used for treating cancers, autoimmune diseases and inflammatory diseases.
    Type: Grant
    Filed: December 16, 2018
    Date of Patent: May 11, 2021
    Assignee: Resolvex Pharmaceuticals Inc.
    Inventors: Liren Tang, Michael Patrick Allen Lyle, Youwen Zhou
  • Substituted Hydroxystilbenes as AhR and Nrf2 modulators and their therapeutic applications
    Publication number: 20190117589
    Abstract: It discloses a compound of formula I that inhibits the activities of numerous of protein kinases involving the signaling of inflammatory cytokines, therefore, the compound can be used for treating cancers, autoimmune diseases and inflammatory diseases.
    Type: Application
    Filed: December 16, 2018
    Publication date: April 25, 2019
    Applicant: Resolvex Pharmaceuticals Inc.
    Inventors: Liren TANG, Michael Patrick Allen LYLE
  • Substituted hydroxystilbenes and their therapeutic applications
    Patent number: 10166201
    Abstract: It discloses a compound of formula I that inhibits the activities of numerous of protein kinases involving the signaling of inflammatory cytokines, therefore, the compound can be used for treating cancers, autoimmune diseases and inflammatory diseases.
    Type: Grant
    Filed: June 29, 2017
    Date of Patent: January 1, 2019
    Assignee: RESOLVEX PHARMACEUTICALS INC.
    Inventors: Liren Tang, Junling Zhang, Tao Guo, Michael Patrick Allen Lyle
  • SUBSTITUTED HYDROXYSTILBENES AND THEIR THERAPEUTIC APPLICATIONS
    Publication number: 20180118667
    Abstract: It discloses a compound of formula I that inhibits the activities of numerous of protein kinases involving the signaling of inflammatory cytokines, therefore, the compound can be used for treating cancers, autoimmune diseases and inflammatory diseases.
    Type: Application
    Filed: June 29, 2017
    Publication date: May 3, 2018
    Applicant: Resolvex Pharmaceuticals Inc.
    Inventors: Liren TANG, Junling ZHANG, Tao GUO, Michael Patrick Allen LYLE
  • Substituted hydroxystilbenes and their therapeutic applications
    Patent number: 9725406
    Abstract: It discloses a compound of formula I that inhibits the activities of numerous of protein kinases involving the signaling of inflammatory cytokines, therefore, the compound can be used for treating cancers, autoimmune diseases and inflammatory diseases.
    Type: Grant
    Filed: October 28, 2016
    Date of Patent: August 8, 2017
    Assignee: RESOLVEX PHARMACEUTICALS INC.
    Inventors: Liren Tang, Junling Zhang, Tao Guo, Michael Patrick Allen Lyle